6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Adenocarcinoma of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, PH; Kataoka, T; Miyake, Y; Nguyen, NT; Sasaki, S; Thi Nguyen, MT; Vo, NT | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Adenocarcinoma of Lung
| Article | Year |
|---|---|
α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human lung adenocarcinoma A549 cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Cell Survival; Chromans; Cyclooxygenase 2; E-Selectin; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Lignans; Lung Neoplasms; Promoter Regions, Genetic; Signal Transduction; Tetrahydronaphthalenes; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2021 |